Study Stopped
Enrollment was stopped due to covid-19 pandemic. An alternate study was initiated under an alternate IRB and clinical trial registration which allowed home exercise instead of in-center exercise after a prolonged pause in enrollment.
Exercise to Treat Frailty and Decreased Physical Function in Transplant Candidates
Exercise as an Intervention to Treat Frailty and Decreased Physical Function in Kidney Transplant Candidates
1 other identifier
interventional
36
1 country
1
Brief Summary
Frailty is a condition characterized by slowness, weakness, low physical activity, wasting, and exhaustion. Frailty increases the risk for adverse outcomes following transplant such as increased length of stay in the hospital, mortality, or graft function. No interventions for frailty are known for patients with renal disease, but exercise programs like pulmonary rehabilitation have been effective in improving frailty in patients with other diseases, such as lung disease. The goal of this study is to test whether exercise will also improve frailty among patients who are waiting for a kidney transplant and who are considered frail or pre-frail.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 3, 2018
CompletedFirst Posted
Study publicly available on registry
May 24, 2018
CompletedStudy Start
First participant enrolled
June 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 26, 2025
CompletedMarch 31, 2025
March 1, 2025
6.6 years
May 3, 2018
March 26, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Frailty Status
Frailty will be determined by Frailty Phenotype (FP) or Short Physical Performance Battery (SPPB) scores. FP is determined by the presence of 3 or more of the following: slowness (measured by gait speed), exhaustion (measured with the CES-D), weakness (measured by hand grip strength), low physical activity level (measured with the MLTPAQ and activity monitoring), and wasting (measured through self-report or by tracking changes in weight). The SPPB consists of a gait speed test, balance testing, and repeated chair stands. A score less than or equal to 10 will be considered frail.
2 Months
Secondary Outcomes (8)
Change in Grip Strength
2 Months
Change in Gait Speed
2 Months
Change in Exhaustion
2 Months
Change in Activity
2 Months
Wasting
2 Months
- +3 more secondary outcomes
Study Arms (1)
Exercise Program
EXPERIMENTALAll participants will attend a 16-session exercise program based on pulmonary rehabilitation and will complete questionnaires and frailty testing.
Interventions
Participants will be asked to complete 2 1-hour exercise sessions per week for 8 weeks (16 total sessions) under the supervision of a licensed respiratory therapist on non-dialysis days. The exercise program will be based on pulmonary rehabilitation and will follow guidelines established by the American Thoracic Society. Exercise sessions will include endurance (treadmill or cycle ergometer), strength (weight resistance), and flexibility training. Exercise sessions will be tailored to individual participants, and participant safety will be monitored during each session.
Eligibility Criteria
You may qualify if:
- Aged 18 years or older
- Consenting to research
- CKD (stages 1-5)
- An SPPB score ≤10 or considered frail or pre-frail by FP
You may not qualify if:
- Younger than 18 years
- Patients listed for heart or lung transplants
- Terminal illness with a prognosis of less than 6 months
- Significant comorbidities that limit rehabilitation potential including pulmonary disease requiring continuous oxygen supplementation, active angina, critical aortic sclerosis, decompensated heart failure, or known ventricular arrhythmia.
- Kidney transplant candidates without cardiac clearance for transplant
- An SPPB score \>10 or not considered frail or pre-frail by FP
- Non-English speaker without availability of adequate interpreter services (safety concern)
- Failure to pass submaximal exercise test
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mayo Cliniclead
Study Sites (1)
Mayo Clinic
Rochester, Minnesota, 55902, United States
Related Publications (2)
Lorenz EC, Hickson LJ, Hogan MC, Kennedy CC. Examining the safety and effectiveness of a 4-week supervised exercise intervention in the treatment of frailty in patients with chronic kidney disease. Clin Kidney J. 2023 Aug 9;16(11):2003-2010. doi: 10.1093/ckj/sfad192. eCollection 2023 Nov.
PMID: 37915911DERIVEDLorenz EC, Hickson LJ, Weatherly RM, Thompson KL, Walker HA, Rasmussen JM, Stewart TL, Garrett JK, Amer H, Kennedy CC. Protocolized exercise improves frailty parameters and lower extremity impairment: A promising prehabilitation strategy for kidney transplant candidates. Clin Transplant. 2020 Sep;34(9):e14017. doi: 10.1111/ctr.14017. Epub 2020 Jul 24.
PMID: 32573816DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Cassie C Kennedy, MD
Mayo Clinic
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
May 3, 2018
First Posted
May 24, 2018
Study Start
June 12, 2018
Primary Completion
January 15, 2025
Study Completion
March 26, 2025
Last Updated
March 31, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share